105 related articles for article (PubMed ID: 2416828)
1. Studies on immunity in hybridoma-bearing mice. B. Immunity against the hybridoma. II. The phenotype and specificity of the immune cell.
Maekawa S; Ovary Z
J Immunol; 1986 Feb; 136(3):1131-5. PubMed ID: 2416828
[TBL] [Abstract][Full Text] [Related]
2. Increased T gamma and T mu cells in BALB/c mice with IgG and IgM plasmacytomas and hybridomas.
Mathur A; Lynch RG
J Immunol; 1986 Jan; 136(2):521-5. PubMed ID: 2934474
[TBL] [Abstract][Full Text] [Related]
3. Mapping of SJL/J reticulum cell sarcoma tumor-associated Ia antigens by T cell hybridomas: characterization of tumor-specific and shared epitopes detected on IE+ allogeneic cells.
Ohnishi K; Bonavida B
J Immunol; 1986 Jul; 137(2):733-40. PubMed ID: 2424977
[TBL] [Abstract][Full Text] [Related]
4. The role of tumor-specific Lyt-1+2- T cells in eradicating tumor cells in vivo. I. Lyt-1+2- T cells do not necessarily require recruitment of host's cytotoxic T cell precursors for implementation of in vivo immunity.
Fujiwara H; Fukuzawa M; Yoshioka T; Nakajima H; Hamaoka T
J Immunol; 1984 Sep; 133(3):1671-6. PubMed ID: 6205091
[TBL] [Abstract][Full Text] [Related]
5. A rat anti-mouse T4 monoclonal antibody (H129.19) inhibits the proliferation of Ia-reactive T cell clones and delineates two phenotypically distinct (T4+, Lyt-2,3-, and T4-, Lyt-2,3+) subsets among anti-Ia cytolytic T cell clones.
Pierres A; Naquet P; Van Agthoven A; Bekkhoucha F; Denizot F; Mishal Z; Schmitt-Verhulst AM; Pierres M
J Immunol; 1984 Jun; 132(6):2775-82. PubMed ID: 6202760
[TBL] [Abstract][Full Text] [Related]
6. Tumor-specific immunity induced by somatic hybrids. II. Elicitation of enhanced immunity against the parent plasmacytoma.
Kim BS
J Immunol; 1979 Aug; 123(2):739-44. PubMed ID: 88483
[TBL] [Abstract][Full Text] [Related]
7. Adoptive transfer of resistance to growth of an idiotype-secreting hybridoma by T cells from idiotypically suppressed mice.
Kresina TF; Baine Y; Nisonoff A
J Immunol; 1983 Mar; 130(3):1478-82. PubMed ID: 6600485
[TBL] [Abstract][Full Text] [Related]
8. Thymus-dependent in vivo suppression of IgE synthesis in a murine IgE-secreting hybridoma.
Mathur A; Kamat DM; Van Ness BG; Lynch RG
J Immunol; 1987 Nov; 139(9):2865-72. PubMed ID: 2959722
[TBL] [Abstract][Full Text] [Related]
9. Generation of somatic variants of a B cell hybrid mediated by a non-cytolytic L3T4+ idiotype-specific T cell.
Ghosh SK; Bankert RB
J Immunol; 1989 Jan; 142(2):409-15. PubMed ID: 2463306
[TBL] [Abstract][Full Text] [Related]
10. T cell-mediated immunity in malaria. I. The Ly phenotype of T cells mediating resistance to Plasmodium yoelii.
Jayawardena AN; Murphy DB; Janeway CA; Gershon RK
J Immunol; 1982 Jul; 129(1):377-81. PubMed ID: 6979570
[TBL] [Abstract][Full Text] [Related]
11. Production of BSF-1 during an in vivo, T-dependent immune response.
Finkelman FD; Ohara J; Goroff DK; Smith J; Villacreses N; Mond JJ; Paul WE
J Immunol; 1986 Nov; 137(9):2878-85. PubMed ID: 3489779
[TBL] [Abstract][Full Text] [Related]
12. Use of I region-restricted, antigen-specific T cell hybridomas to produce idiotypically specific anti-receptor antibodies.
White J; Haskins KM; Marrack P; Kappler J
J Immunol; 1983 Mar; 130(3):1033-7. PubMed ID: 6185566
[TBL] [Abstract][Full Text] [Related]
13. Growth inhibition of a B cell leukemia: evidence implicating an anti-idiotype immune response for protective tumor immunity.
Ciavarra RP; Vitetta ES; Forman J
J Immunol; 1986 Aug; 137(4):1371-5. PubMed ID: 2426362
[TBL] [Abstract][Full Text] [Related]
14. Naturally occurring cytotoxic T lymphocyte precursors with specificity for an Ig idiotype.
Dohi Y; Yamada K; Ohno N; Aoki M; Takagaki Y; Nisonoff A; Shinka S
J Immunol; 1988 Dec; 141(11):3804-9. PubMed ID: 2460550
[TBL] [Abstract][Full Text] [Related]
15. Continuous cytotoxic T cell lines reactive against murine plasmacytoma tumor-associated antigens.
Giorgi JV; Warner NL
J Immunol; 1981 Jan; 126(1):322-30. PubMed ID: 6161166
[TBL] [Abstract][Full Text] [Related]
16. Studies on immunity in hybridoma-bearing mice. A. Immune response to antigens. II. inhibition of production of anti-dinitrophenyl antibodies in mice which have rejected the B 53 anti-dinitrophenyl-producing IgE hybridoma.
Yin JZ; Furusawa S; Hirano T; Ovary Z
Int Arch Allergy Appl Immunol; 1987; 83(4):414-22. PubMed ID: 2440817
[TBL] [Abstract][Full Text] [Related]
17. Inducing oral immune regulation of hepatitis B virus envelope proteins suppresses the growth of hepatocellular carcinoma in mice.
Gotsman I; Alper R; Klein A; Rabbani E; Engelhardt D; Ilan Y
Cancer; 2002 Jan; 94(2):406-14. PubMed ID: 11900226
[TBL] [Abstract][Full Text] [Related]
18. Investigations into the nature of Igh-V region-restricted T cell interactions by using antibodies to antigens on methylcholanthrene-induced sarcomas. I. Analysis of an Igh-V-restricted suppressor-inducer factor.
Flood PM
J Immunol; 1985 Mar; 134(3):1665-72. PubMed ID: 2578515
[TBL] [Abstract][Full Text] [Related]
19. Enhancement of passive antilisterial immunity and change of Lyt phenotype following in vitro stimulation of murine lymphoid cells from immune donors.
Barry RA; Hinrichs DJ
Clin Invest Med; 1984; 7(4):303-9. PubMed ID: 6442653
[TBL] [Abstract][Full Text] [Related]
20. Specific lymphocyte-target cell conjugate formation between tumor-specific helper T-cell hybridomas and IA-bearing RCS tumors and IE-bearing allogeneic cells. I. Role of Ia and both L3T4 and LFA-1 antigens in recognition/binding.
Ohnishi K; Bonavida B
J Immunol; 1986 Dec; 137(11):3681-8. PubMed ID: 2946766
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
